| 货号 | 物种 | 产品描述 | 蛋白结构 | 纯度 | 活性 |
|---|---|---|---|---|---|
| LA3-H5222 |
 Human |
Human LAG-3 / CD223 Protein, His Tag |
 |
  |
  |
| LA3-M52H5 |
 Mouse |
Mouse LAG-3 / CD223 Protein, His Tag |
 |
 |
|
| LA3-R52H5 |
 Rat |
Rat LAG3 / CD223 Protein, His Tag |
 |
 |
|
| LA3-H5255 |
Human |
Human LAG3 / CD223 Protein, Fc Tag (HPLC-verified) |
 |
   |
 |
| LA3-C52A0 |
 Cynomolgus |
Cynomolgus LAG-3 / CD223 Protein, Mouse IgG2a Fc Tag |
 |
 |
 |
| LA3-H52Aa |
Human |
Human LAG-3 / CD223 Protein, Mouse IgG2a Fc Tag |
 |
 |
 |
| LA3-C5252 |
Cynomolgus |
Cynomolgus LAG-3 / CD223 Protein, Fc Tag |
 |
 |
 |
| LA3-M52Ha |
Marmoset |
Marmoset LAG-3 / CD223 Protein, His Tag |
 |
 |
 |
| LA3-H82F3 |
Human |
Biotinylated Human LAG-3 / CD223 Protein, Mouse IgG2a Fc,Avitag |
 |
 |
 |
| LA3-H522a |
Human |
Human LAG-3 / CD223 Protein, His Tag, low endotoxin |
 |
 |
 |
| LA3-H525c |
Human |
Human LAG-3 / CD223 Protein, Llama IgG2b Fc Tag, low endotoxin |
 |
 |
 |
| LA3-H82E5 |
Human |
Biotinylated Human LAG-3 / CD223 Protein, His,Avitag |
 |
 |
 |
| LA3-H82Fb |
Human |
Biotinylated Human LAG-3 / CD223 Protein, Fc,Avitag |
 |
 |
 |
| LA3-HP2H3 |
Human |
PE-Labeled Human LAG-3 / CD223 Protein, His Tag (recommended for neutralizing assay) |
 |
| 英文名称 | 研发代码 | 研发阶段 | 公司 | 适应症 | 临床试验 |
|---|---|---|---|---|---|
| Anti-LAG-3 mAb (Regeneron Pharmaceuticals/Sanofi) | REGN-3767 | 临床一期 | 再生元制药, 赛诺菲 | 恶性肿瘤 | |
| Nivolumab/Relatlimab | BMS-936558/BMS-986016; BMS-986213 | 临床三期 | 百时美施贵宝 | 黑色素瘤 | 详情 |
| Chlorogenic acid | 临床三期 | 四川九章生物科技 | 成胶质细胞瘤 | 详情 | |
| TSR-033 | TSR-033,TSR 033,TSR033 | 临床一期 | AnaptysBio, Tesaro, 葛兰素史克 | 实体瘤 | 详情 |
| BI-754111 | BI-754111 | 临床二期 | 勃林格殷格翰 | 非小细胞肺癌, 实体瘤, 头颈癌 | 详情 |
| Ieramilimab | LAG-525; IMP-701 | 临床二期 | Immutep, 诺华, CoStim | 三阴性乳腺癌, 神经内分泌肿瘤, 小细胞肺癌, 胃腺癌, 弥漫大B细胞淋巴瘤, 食道腺癌, 去势抵抗性前列腺癌, 实体瘤, 软组织肉瘤, 卵巢癌, 血液癌症, 黑色素瘤 | 详情 |
| IMP-761 | IMP-761 | 临床前 | Immutep | 自身免疫疾病 | |
| IBI110 | IBI110,IBI-110 | 临床申请 | 信达生物制药(苏州) | 癌症 | |
| XmAb-22841 | XmAb-22841 | 临床一期 | Xencor | 癌症 | 详情 |
| FS 118 | FS-118 | 临床一期 | F-star, 默克雪兰诺 | 血液系统恶性肿瘤, 实体瘤 | 详情 |
| Relatlimab | BMS-986016; ONO-4482 | 临床三期 | 百时美施贵宝, 小野制药 | 黑色素瘤 | 详情 |
| Sym-022 | Sym-022 | 临床一期 | Symphogen | 实体瘤, 淋巴瘤 | 详情 |
| MGD-013 | MGD-013,PD-1 X LAG-3,MGD013; MGD 013 | 临床一期 | MacroGenics, 再鼎医药 | 血液系统恶性肿瘤, 实体瘤 | 详情 |
| GSK-2831781 | GSK-2831781; ImmuTune-IMP731; IMP-731, GSK2831781; IMP731 ,GSK‘781 | 临床二期 | Prima BioMed, 葛兰素史克 | 溃疡性结肠炎 | 详情 |
| INCAGN-2385 | INCAGN-02385; INCAGN-2385 | 临床一期 | Agenus | 实体瘤 |
